Cue Biopharma, Inc. (CUE)
26.56
+3.38
(+14.60%)
USD |
NASDAQ |
Aug 25, 16:00
26.56
0.00 (0.00%)
After-Hours: 17:05
Cue Biopharma Price to Book Value : 60.14 for Aug. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 52.48 |
| August 21, 2026 | 54.29 |
| August 20, 2026 | 55.71 |
| August 19, 2026 | 59.49 |
| August 18, 2026 | 58.18 |
| August 17, 2026 | 62.57 |
| August 14, 2026 | 77.42 |
| August 13, 2026 | 70.36 |
| August 12, 2026 | 68.87 |
| August 11, 2026 | 63.93 |
| August 10, 2026 | 59.09 |
| August 07, 2026 | 61.39 |
| August 06, 2026 | 61.15 |
| August 05, 2026 | 60.33 |
| August 04, 2026 | 60.22 |
| August 03, 2026 | 60.83 |
| July 31, 2026 | 60.76 |
| July 30, 2026 | 68.82 |
| July 29, 2026 | 63.41 |
| July 28, 2026 | 68.48 |
| July 27, 2026 | 73.73 |
| July 24, 2026 | 72.71 |
| July 23, 2026 | 74.91 |
| July 22, 2026 | 77.42 |
| July 21, 2026 | 75.75 |
| Date | Value |
|---|---|
| July 20, 2026 | 70.06 |
| July 17, 2026 | 70.54 |
| July 16, 2026 | 62.91 |
| July 15, 2026 | 64.50 |
| July 14, 2026 | 70.81 |
| July 13, 2026 | 70.00 |
| July 10, 2026 | 83.26 |
| July 09, 2026 | 82.65 |
| July 08, 2026 | 80.03 |
| July 07, 2026 | 75.59 |
| July 06, 2026 | 73.56 |
| July 02, 2026 | 63.98 |
| July 01, 2026 | 64.16 |
| June 30, 2026 | 71.45 |
| June 29, 2026 | 4.584 |
| June 26, 2026 | 3.825 |
| June 25, 2026 | 3.848 |
| June 24, 2026 | 3.919 |
| June 23, 2026 | 4.053 |
| June 22, 2026 | 4.630 |
| June 18, 2026 | 4.288 |
| June 17, 2026 | 4.027 |
| June 16, 2026 | 3.599 |
| June 15, 2026 | 3.887 |
| June 12, 2026 | 3.696 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ironwood Pharmaceuticals, Inc. | -- |
| Fortress Biotech, Inc. | 0.5753 |
| Equillium, Inc. | 2.462 |
| Legend Biotech Corp. | 3.355 |
| Nurix Therapeutics, Inc. | 6.944 |
Price to Book Value Related Metrics
| PS Ratio | 3.209 |
| PEG Ratio | -0.0033 |
| Price | 26.56 |
| Earnings Yield | -101.6% |
| Market Cap | 138.92M |
| PEGY Ratio | -0.0033 |